Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1Genitourinary 1

Conditions

Social Isolation 1Prostatic Neoplasms 1Neoplasms 1Depression 1Communication 1Anxiety Disorders 1

Interventions

Specimen Handling 267Magnetic Resonance Spectroscopy 218pembrolizumab 203Carboplatin 170Cisplatin 137Biopsy 136Cyclophosphamide 131Paclitaxel 120Nivolumab 110Bevacizumab 104Gemcitabine 102Radiotherapy 85Dexamethasone 77Pemetrexed 75atezolizumab 73Fluorouracil 71fludarabine 69Doxorubicin 68Leucovorin 66Docetaxel 66Radiation 65Oxaliplatin 62Rituximab 60venetoclax 58Prednisone 58Cetuximab 54durvalumab 53Vincristine 52Etoposide 51130-nm albumin-bound paclitaxel 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Artificial Intelligence × 30 days × Clear all
NCT06909643 2026-06-03

Development and Validation of a Multimodal Fusion Artificial Intelligence Model for Predicting the Efficacy of Neoadjuvant Treatment of Bladder Cancer

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Completed
469 enrolled
Tumor-Agnostic

Neoplasms

NCT06964412 2026-05-29

The Use of Artificial Intelligence Generated Contours in Radiation Planning of the Prostate Brachytherapy

Brigham and Women's Hospital

Phase NA Active not recruiting
36 enrolled
Genitourinary

Prostatic Neoplasms

NCT07454460 2026-05-22

AYA-PeerConnect: A Communication Coaching Intervention for Adolescent/Young Adult Cancer Survivors (AYACS)

Milton S. Hershey Medical Center

Phase NA Recruiting
10 enrolled

Anxiety Disorders, Communication, Depression, Social Isolation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡